| Authors: |
Patel LR; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas, Houston, TX, USA.; McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA., Stratton SA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McLaughlin M; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Krause P; Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, US., Allton K; The Neurodegeneration Consortium, Therapeutics Discovery, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rivas AL; School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA., Barbosa D; Department of Molecular Biology, University of Texas Southwestern, Dallas, TX, USA., Hart T; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barton MC; Division of Oncological Sciences, Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, US. |
